An innovative implantable device and management platform to prevent chronic fluid congestion

FILBERT is an implantable peritoneal ultrafiltration system that enables continuous fluid management for diuretic-resistant CHF patients, improving quality of life and reducing healthcare costs.

Subsidie
€ 2.500.000
2023

Projectdetails

Introduction

Pathologic fluid overload is a main clinical complication of congestive heart failure (CHF). CHF is a severe chronic disease affecting approximately 28 million people worldwide.

Patient Challenges

Around 8 million CHF patients are resistant to oral medications and undergo frequent hospitalizations to remove extra fluids with aggressive acute treatments, all carrying severe complications. None of these treatments can prevent fluid accumulation.

Innovation by Paragate Medical

The Israeli SME Paragate Medical has developed FILBERT, a unique implantable peritoneal ultrafiltration system for diuretic-resistant CHF patients.

Key Features of FILBERT

  • Enables 24/7 monitoring and gentle draining of extra fluids in the urinary system, preventing their accumulation.
  • A remote treatment management platform allows physicians to continuously control patients’ conditions and timely adjust therapy to prevent fluid accumulation.

Impact on Healthcare

FILBERT shifts the paradigm of fluid congestion care from the hospital to the home, improving patients’ quality of life and saving billions for healthcare systems.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.500.000
Totale projectbegroting€ 3.994.993

Tijdlijn

Startdatum1-8-2023
Einddatum31-7-2025
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • PARAGATE MEDICAL LTDpenvoerder

Land(en)

Israel

Vergelijkbare projecten binnen EIC Accelerator

EIC Accelerator

The first heart failure therapy management point-of-care device with multiplex and multimodal sensor

CardioCap is a handheld POC device that uses a finger-prick blood sample to simultaneously assess heart failure severity through four biomarkers, aiming to reduce re-hospitalization and mortality rates by 30%.

€ 2.499.999
EIC Accelerator

Development and clinical evaluation of an end-to-end Heart Failure management solution powered by predictive AI

Implicity is developing an AI-driven platform to predict heart failure events using cardiac device data, enhancing patient care and reducing hospitalizations through tailored insights and management tools.

€ 2.488.359
EIC Accelerator

ContraBand: the only heart failure medical device that is placed outside the heart

ContraBand is an implantable device designed to restore heart function in CHF patients, aiming for a 2024 launch and generating significant revenue while creating over 95 jobs in Europe.

€ 2.499.999
EIC Accelerator

Saving patients from severe heart failure

The ICOMS FlowMaker® is a novel intracardiac assist device designed to improve the quality of life for severe heart failure patients, aiming for EU market entry by 2026 through clinical trials.

€ 2.500.000
EIC Accelerator

Transcatheter Ventricular Repair Device for treatment of Heart Failure Patients

Cardiac Success aims to develop the V-sling, a transcatheter device to enhance heart function in heart failure patients, through product optimization and pre-clinical testing.

€ 2.500.000

Vergelijkbare projecten uit andere regelingen

1.1 - Onderz...

Acute Heart Failure

Het project richt zich op het ontwikkelen van een platform voor real-time meting van urine-biomarkers bij acuut hartfalen.

€ 598.145
EIC Transition

Novel microsensing platform for remote patient monitoring

The FORESEE project aims to advance implantable microstimulators for remote monitoring of chronic heart failure, enhancing patient care and market access for 10.5 million potential users.

€ 2.499.051
Mkb-innovati...

Boost of Diuretics

Het project ontwikkelt een goedkope en effectieve methode voor thuismonitoring van hart- en longfalen, gericht op het tijdig signaleren van verslechtering om zorglasten te verlichten.

€ 20.000
Mkb-innovati...

HeartGuard: Thuismonitoring van patiënt met hartfalen halveert aantal ziekenhuisopnamen

HeartGuard ontwikkelt een thuismonitoringsysteem voor hartfalen, wat ziekenhuisopnames met 44% kan verminderen.

€ 332.500
Mkb-innovati...

INPUT - OUTPUT DRINKBEKERS

Het project ontwikkelt een "Drinkbeker" en polsbandje om de vochtinname van ouderen te monitoren via een app, ter preventie van complicaties door uitdroging.

€ 20.000